Serum level of C-reactive protein may be a marker for proliferation of esophageal carcinoma.
We herein show the significance of the serum level of C-reactive protein as an indicator of proliferation in esophageal carcinoma. The patient was a 70-year-old male with advanced squamous cell carcinoma in the lower location of the esophagus, and in whom an esophagectomy and reconstruction with a gastric tube through the intrathoracic route was performed. When he was later hospitalized again due to recurrent tumor, the serum C-reactive protein level was 5.0 mg/dL and it later increased to 10.8 mg/dL along with the proliferation of the tumor. After performing chemotherapy, the concentration of the serum C-reactive protein decreased to the negative level with a simultaneous improvement in his cachexic condition and the eventual disappearance of the tumor.
Nozoe
T
T
Department of Gastroenterology, Saiseikai Yahata General Hospital, Kitakyushu, Japan.
Matsumata
T
T
Sugimachi
K
K
D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000378:metabolism*; D002294:Carcinoma, Squamous Cell / Q000097:blood* / Q000188:drug therapy / Q000473:pathology* / Q000556:secondary / Q000601:surgery; D004938:Esophageal Neoplasms / Q000097:blood* / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery; D016629:Esophagectomy; D006801:Humans; D008113:Liver Neoplasms / Q000097:blood / Q000556:secondary; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000097:blood* / Q000188:drug therapy / Q000473:pathology
D000970:Antineoplastic Agents; D015415:Biomarkers; D002097:C-Reactive Protein